Enkephalins modify granulocyte-endothelial interactions by stimulating prostacyclin production

Area of Science:

• Immunology
• Neuroscience
• Vascular Biology

Background:

• Granulocyte (PMN)-endothelial interactions are key in vascular injury and atherogenesis.
• Endogenous opioid peptides (e.g., enkephalins) may modulate these interactions.

Purpose of the Study:

• To investigate the role of enkephalins in mitigating granulocyte-induced endothelial damage.
• To explore the effect of enkephalins on prostacyclin production and PMN adherence to endothelial cells.

Main Methods:

• Human umbilical vein endothelial cells (HUEC) were exposed to Met5-enkephalin with arachidonic acid or thrombin.
• Prostacyclin release (6-keto-PGF1 alpha) was measured.
• PMN adherence and endothelial cell (51Cr-leakage) damage were assessed with and without enkephalin analogues.

Main Results:

• Enkephalin significantly increased prostacyclin release induced by arachidonic acid and thrombin.
• Naloxone abolished the enkephalin-mediated increase in prostacyclin.
• Enkephalin reduced PMN adherence to HUEC and subsequent endothelial cell damage.

Conclusions:

• Endogenous opioid peptides, such as enkephalins, protect endothelial cells from PMN-mediated injury.
• Enkephalins enhance prostacyclin production, a mechanism that dampens inflammatory responses.
• This neurohumoral-inflammatory link offers insights into stress-related vascular diseases.